摘要
YAP and TAZ are highly related transcriptional regulators pervasively activated in human malignancies. Recent work indicates that, remarkably, YAP/TAZ are essential for cancer initiation or growth of most solid tumors. Their activation induces cancer stem cell attributes, proliferation, chemoresistance, and metastasis. YAP/TAZ are sensors of the structural and mechanical features of the cell microenvironment. A number of cancer-associated extrinsic and intrinsic cues conspire to overrule the YAP-inhibiting microenvironment of normal tissues, including changes in mechanotransduction, inflammation, oncogenic signaling, and regulation of the Hippo pathway. Addiction to YAP/TAZ thus potentially represents a central cancer vulnerability that may be exploited therapeutically. YAP and TAZ are highly related transcriptional regulators pervasively activated in human malignancies. Recent work indicates that, remarkably, YAP/TAZ are essential for cancer initiation or growth of most solid tumors. Their activation induces cancer stem cell attributes, proliferation, chemoresistance, and metastasis. YAP/TAZ are sensors of the structural and mechanical features of the cell microenvironment. A number of cancer-associated extrinsic and intrinsic cues conspire to overrule the YAP-inhibiting microenvironment of normal tissues, including changes in mechanotransduction, inflammation, oncogenic signaling, and regulation of the Hippo pathway. Addiction to YAP/TAZ thus potentially represents a central cancer vulnerability that may be exploited therapeutically. Research on the biology and regulation of YAP/TAZ drew its initial inspiration from pioneering studies in Drosophila. YAP/TAZ are indeed orthologs of Drosophila Yorkie (Huang et al., 2005Huang J. Wu S. Barrera J. Matthews K. Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP.Cell. 2005; 122: 421-434Abstract Full Text Full Text PDF PubMed Scopus (699) Google Scholar), and several of the biological traits now assigned to YAP/TAZ were in fact initially discovered in fly tissues in the context of some remarkable organ-overgrowth phenotypes initially observed in mutants of the Hippo cascade (see Box 1).Box 1The Core Hippo Kinase CassetteMammalian YAP and TAZ were discovered by M. Sudol and M. Yaffe (Kanai et al., 2000Kanai F. Marignani P.A. Sarbassova D. Yagi R. Hall R.A. Donowitz M. Hisaminato A. Fujiwara T. Ito Y. Cantley L.C. Yaffe M.B. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.EMBO J. 2000; 19: 6778-6791Crossref PubMed Scopus (340) Google Scholar, Sudol, 1994Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product.Oncogene. 1994; 9: 2145-2152PubMed Google Scholar), but their function started to be understood only after it became clear that they were homologs of Drosophila Yorkie, the nuclear mediator of the Drosophila Hippo cascade (Huang et al., 2005Huang J. Wu S. Barrera J. Matthews K. Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP.Cell. 2005; 122: 421-434Abstract Full Text Full Text PDF PubMed Scopus (699) Google Scholar). In fact, Hippo pathway components were originally discovered in the fly before Yorkie by means of genetic screens aimed at isolating genes regulating the growth of larval tissues (Harvey et al., 2003Harvey K.F. Pfleger C.M. Hariharan I.K. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis.Cell. 2003; 114: 457-467Abstract Full Text Full Text PDF PubMed Scopus (446) Google Scholar, Justice et al., 1995Justice R.W. Zilian O. Woods D.F. Noll M. Bryant P.J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation.Genes Dev. 1995; 9: 534-546Crossref PubMed Scopus (0) Google Scholar, Tapon et al., 2002Tapon N. Harvey K.F. Bell D.W. Wahrer D.C. Schiripo T.A. Haber D. Hariharan I.K. Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines.Cell. 2002; 110: 467-478Abstract Full Text Full Text PDF PubMed Scopus (435) Google Scholar, Wu et al., 2003Wu S. Huang J. Dong J. Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts.Cell. 2003; 114: 445-456Abstract Full Text Full Text PDF PubMed Scopus (501) Google Scholar, Xu et al., 1995Xu T. Wang W. Zhang S. Stewart R.A. Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase.Development. 1995; 121: 1053-1063Crossref PubMed Google Scholar; reviewed in Pan, 2010Pan D. The hippo signaling pathway in development and cancer.Dev. Cell. 2010; 19: 491-505Abstract Full Text Full Text PDF PubMed Scopus (790) Google Scholar). These findings revealed that the Hippo pathway is a potent tumor suppressor of fly tissues; mutations inactivating Hippo pathway components invariably cause overgrowth of larval tissues and the emergence of tumors. Yorkie was identified only in 2005 as Warts-interacting protein (Huang et al., 2005Huang J. Wu S. Barrera J. Matthews K. Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP.Cell. 2005; 122: 421-434Abstract Full Text Full Text PDF PubMed Scopus (699) Google Scholar).The Hippo cascade is an evolutionary conserved module of two kinases, MST1/2 and LATS1/2 (corresponding to Drosophila's Hippo and Warts, respectively). MST1/2, aided by its partner Sav1 (Salvador), stimulates LATS kinase activity by directly phosphorylating LATS1/2 and the LATS co-factor MOB1 (reviewed in Meng et al., 2016Meng Z. Moroishi T. Guan K.L. Mechanisms of Hippo pathway regulation.Genes Dev. 2016; 30: 1-17Crossref PubMed Scopus (74) Google Scholar). Members of the MAP4K4 have been recently reported to substitute MST1/2 for LATS phosphorylation (Li et al., 2014Li Q. Li S. Mana-Capelli S. Roth Flach R.J. Danai L.V. Amcheslavsky A. Nie Y. Kaneko S. Yao X. Chen X. et al.The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila.Dev. Cell. 2014; 31: 291-304Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar, Meng et al., 2015Meng Z. Moroishi T. Mottier-Pavie V. Plouffe S.W. Hansen C.G. Hong A.W. Park H.W. Mo J.S. Lu W. Lu S. et al.MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.Nat. Commun. 2015; 6: 8357Crossref PubMed Google Scholar). NF2 (or Merlin) is a potent upstream component of the Hippo cascade; in epithelial cells, this protein is located at cell-cell junctions where it strengthens adhesion and also serves as a scaffold for the core Hippo kinases (Lallemand et al., 2003Lallemand D. Curto M. Saotome I. Giovannini M. McClatchey A.I. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.Genes Dev. 2003; 17: 1090-1100Crossref PubMed Scopus (204) Google Scholar, Yin et al., 2013Yin F. Yu J. Zheng Y. Chen Q. Zhang N. Pan D. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.Cell. 2013; 154: 1342-1355Abstract Full Text Full Text PDF PubMed Scopus (125) Google Scholar). Activated LATS1/2 directly phosphorylate YAP and TAZ, inhibiting them by causing their translocation in the cytoplasm and/or degradation (Meng et al., 2016Meng Z. Moroishi T. Guan K.L. Mechanisms of Hippo pathway regulation.Genes Dev. 2016; 30: 1-17Crossref PubMed Scopus (74) Google Scholar). TAZ phosphorylation prominently affects TAZ stability, in part through formation of an LATS/CK1(ɛ/δ) phosphodegron leading to β-TrCP recognition, ubiquitination, and proteosomal degradation (reviewed in Meng et al., 2016Meng Z. Moroishi T. Guan K.L. Mechanisms of Hippo pathway regulation.Genes Dev. 2016; 30: 1-17Crossref PubMed Scopus (74) Google Scholar). YAP phosphorylation favors primarily its cytoplasmic localization through only partially understood mechanisms. LATS-mediated phosphorylation on YAPS127 (corresponding to mouse S112) generates a unique 14-3-3 binding site that has been long thought to mediate YAP cytoplasmic anchoring. However, this notion has been challenged by recent genetic data with mouse knockin strains in which wild-type YAP has been substituted with a YAPS112A allele; this substitution is inconsequential for mammalian development and adult tissue homeostasis, ruling out YAP/14-3-3 association as the main determinant of YAP regulation (Chen et al., 2015Chen Q. Zhang N. Xie R. Wang W. Cai J. Choi K.S. David K.K. Huang B. Yabuta N. Nojima H. et al.Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.Genes Dev. 2015; 29: 1285-1297Crossref PubMed Scopus (25) Google Scholar). It is possible that other YAP/TAZ cytoplasmic anchors may require LATS phosphorylation. Moreover, YAP/TAZ integrate LATS-dependent and LATS-independent regulation making YAP/TAZ phosphorylation by LATS an important yet not an absolute determinant of their nuclear localization or stability (Aragona et al., 2013Aragona M. Panciera T. Manfrin A. Giulitti S. Michielin F. Elvassore N. Dupont S. Piccolo S. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors.Cell. 2013; 154: 1047-1059Abstract Full Text Full Text PDF PubMed Scopus (289) Google Scholar, Barry et al., 2013Barry E.R. Morikawa T. Butler B.L. Shrestha K. de la Rosa R. Yan K.S. Fuchs C.S. Magness S.T. Smits R. Ogino S. et al.Restriction of intestinal stem cell expansion and the regenerative response by YAP.Nature. 2013; 493: 106-110Crossref PubMed Scopus (173) Google Scholar, Das et al., 2016Das A. Fischer R.S. Pan D. Waterman C.M. YAP nuclear localization in the absence of cell-cell contact is mediated by a filamentous actin-dependent, myosin II- and phospho-YAP independent pathway during ECM mechanosensing.J. Biol. Chem. 2016; 291: 6096-6110Crossref PubMed Scopus (0) Google Scholar, Dupont et al., 2011Dupont S. Morsut L. Aragona M. Enzo E. Giulitti S. Cordenonsi M. Zanconato F. Le Digabel J. Forcato M. Bicciato S. et al.Role of YAP/TAZ in mechanotransduction.Nature. 2011; 474: 179-183Crossref PubMed Scopus (988) Google Scholar, Rashidian et al., 2015Rashidian J. Le Scolan E. Ji X. Zhu Q. Mulvihill M.M. Nomura D. Luo K. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.Sci. Signal. 2015; 8: ra14Crossref PubMed Scopus (10) Google Scholar, Ren et al., 2010Ren F. Zhang L. Jiang J. Hippo signaling regulates Yorkie nuclear localization and activity through 14-3-3 dependent and independent mechanisms.Dev. Biol. 2010; 337: 303-312Crossref PubMed Scopus (0) Google Scholar, Sorrentino et al., 2014Sorrentino G. Ruggeri N. Specchia V. Cordenonsi M. Mano M. Dupont S. Manfrin A. Ingallina E. Sommaggio R. Piazza S. et al.Metabolic control of YAP and TAZ by the mevalonate pathway.Nat. Cell Biol. 2014; 16: 357-366Crossref PubMed Scopus (134) Google Scholar, Wada et al., 2011Wada K. Itoga K. Okano T. Yonemura S. Sasaki H. Hippo pathway regulation by cell morphology and stress fibers.Development. 2011; 138: 3907-3914Crossref PubMed Scopus (239) Google Scholar, Wang et al., 2014Wang Z. Wu Y. Wang H. Zhang Y. Mei L. Fang X. Zhang X. Zhang F. Chen H. Liu Y. et al.Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.Proc. Natl. Acad. Sci. USA. 2014; 111: E89-E98Crossref PubMed Scopus (81) Google Scholar). Mammalian YAP and TAZ were discovered by M. Sudol and M. Yaffe (Kanai et al., 2000Kanai F. Marignani P.A. Sarbassova D. Yagi R. Hall R.A. Donowitz M. Hisaminato A. Fujiwara T. Ito Y. Cantley L.C. Yaffe M.B. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.EMBO J. 2000; 19: 6778-6791Crossref PubMed Scopus (340) Google Scholar, Sudol, 1994Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product.Oncogene. 1994; 9: 2145-2152PubMed Google Scholar), but their function started to be understood only after it became clear that they were homologs of Drosophila Yorkie, the nuclear mediator of the Drosophila Hippo cascade (Huang et al., 2005Huang J. Wu S. Barrera J. Matthews K. Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP.Cell. 2005; 122: 421-434Abstract Full Text Full Text PDF PubMed Scopus (699) Google Scholar). In fact, Hippo pathway components were originally discovered in the fly before Yorkie by means of genetic screens aimed at isolating genes regulating the growth of larval tissues (Harvey et al., 2003Harvey K.F. Pfleger C.M. Hariharan I.K. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis.Cell. 2003; 114: 457-467Abstract Full Text Full Text PDF PubMed Scopus (446) Google Scholar, Justice et al., 1995Justice R.W. Zilian O. Woods D.F. Noll M. Bryant P.J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation.Genes Dev. 1995; 9: 534-546Crossref PubMed Scopus (0) Google Scholar, Tapon et al., 2002Tapon N. Harvey K.F. Bell D.W. Wahrer D.C. Schiripo T.A. Haber D. Hariharan I.K. Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines.Cell. 2002; 110: 467-478Abstract Full Text Full Text PDF PubMed Scopus (435) Google Scholar, Wu et al., 2003Wu S. Huang J. Dong J. Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts.Cell. 2003; 114: 445-456Abstract Full Text Full Text PDF PubMed Scopus (501) Google Scholar, Xu et al., 1995Xu T. Wang W. Zhang S. Stewart R.A. Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase.Development. 1995; 121: 1053-1063Crossref PubMed Google Scholar; reviewed in Pan, 2010Pan D. The hippo signaling pathway in development and cancer.Dev. Cell. 2010; 19: 491-505Abstract Full Text Full Text PDF PubMed Scopus (790) Google Scholar). These findings revealed that the Hippo pathway is a potent tumor suppressor of fly tissues; mutations inactivating Hippo pathway components invariably cause overgrowth of larval tissues and the emergence of tumors. Yorkie was identified only in 2005 as Warts-interacting protein (Huang et al., 2005Huang J. Wu S. Barrera J. Matthews K. Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP.Cell. 2005; 122: 421-434Abstract Full Text Full Text PDF PubMed Scopus (699) Google Scholar). The Hippo cascade is an evolutionary conserved module of two kinases, MST1/2 and LATS1/2 (corresponding to Drosophila's Hippo and Warts, respectively). MST1/2, aided by its partner Sav1 (Salvador), stimulates LATS kinase activity by directly phosphorylating LATS1/2 and the LATS co-factor MOB1 (reviewed in Meng et al., 2016Meng Z. Moroishi T. Guan K.L. Mechanisms of Hippo pathway regulation.Genes Dev. 2016; 30: 1-17Crossref PubMed Scopus (74) Google Scholar). Members of the MAP4K4 have been recently reported to substitute MST1/2 for LATS phosphorylation (Li et al., 2014Li Q. Li S. Mana-Capelli S. Roth Flach R.J. Danai L.V. Amcheslavsky A. Nie Y. Kaneko S. Yao X. Chen X. et al.The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila.Dev. Cell. 2014; 31: 291-304Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar, Meng et al., 2015Meng Z. Moroishi T. Mottier-Pavie V. Plouffe S.W. Hansen C.G. Hong A.W. Park H.W. Mo J.S. Lu W. Lu S. et al.MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.Nat. Commun. 2015; 6: 8357Crossref PubMed Google Scholar). NF2 (or Merlin) is a potent upstream component of the Hippo cascade; in epithelial cells, this protein is located at cell-cell junctions where it strengthens adhesion and also serves as a scaffold for the core Hippo kinases (Lallemand et al., 2003Lallemand D. Curto M. Saotome I. Giovannini M. McClatchey A.I. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.Genes Dev. 2003; 17: 1090-1100Crossref PubMed Scopus (204) Google Scholar, Yin et al., 2013Yin F. Yu J. Zheng Y. Chen Q. Zhang N. Pan D. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.Cell. 2013; 154: 1342-1355Abstract Full Text Full Text PDF PubMed Scopus (125) Google Scholar). Activated LATS1/2 directly phosphorylate YAP and TAZ, inhibiting them by causing their translocation in the cytoplasm and/or degradation (Meng et al., 2016Meng Z. Moroishi T. Guan K.L. Mechanisms of Hippo pathway regulation.Genes Dev. 2016; 30: 1-17Crossref PubMed Scopus (74) Google Scholar). TAZ phosphorylation prominently affects TAZ stability, in part through formation of an LATS/CK1(ɛ/δ) phosphodegron leading to β-TrCP recognition, ubiquitination, and proteosomal degradation (reviewed in Meng et al., 2016Meng Z. Moroishi T. Guan K.L. Mechanisms of Hippo pathway regulation.Genes Dev. 2016; 30: 1-17Crossref PubMed Scopus (74) Google Scholar). YAP phosphorylation favors primarily its cytoplasmic localization through only partially understood mechanisms. LATS-mediated phosphorylation on YAPS127 (corresponding to mouse S112) generates a unique 14-3-3 binding site that has been long thought to mediate YAP cytoplasmic anchoring. However, this notion has been challenged by recent genetic data with mouse knockin strains in which wild-type YAP has been substituted with a YAPS112A allele; this substitution is inconsequential for mammalian development and adult tissue homeostasis, ruling out YAP/14-3-3 association as the main determinant of YAP regulation (Chen et al., 2015Chen Q. Zhang N. Xie R. Wang W. Cai J. Choi K.S. David K.K. Huang B. Yabuta N. Nojima H. et al.Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.Genes Dev. 2015; 29: 1285-1297Crossref PubMed Scopus (25) Google Scholar). It is possible that other YAP/TAZ cytoplasmic anchors may require LATS phosphorylation. Moreover, YAP/TAZ integrate LATS-dependent and LATS-independent regulation making YAP/TAZ phosphorylation by LATS an important yet not an absolute determinant of their nuclear localization or stability (Aragona et al., 2013Aragona M. Panciera T. Manfrin A. Giulitti S. Michielin F. Elvassore N. Dupont S. Piccolo S. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors.Cell. 2013; 154: 1047-1059Abstract Full Text Full Text PDF PubMed Scopus (289) Google Scholar, Barry et al., 2013Barry E.R. Morikawa T. Butler B.L. Shrestha K. de la Rosa R. Yan K.S. Fuchs C.S. Magness S.T. Smits R. Ogino S. et al.Restriction of intestinal stem cell expansion and the regenerative response by YAP.Nature. 2013; 493: 106-110Crossref PubMed Scopus (173) Google Scholar, Das et al., 2016Das A. Fischer R.S. Pan D. Waterman C.M. YAP nuclear localization in the absence of cell-cell contact is mediated by a filamentous actin-dependent, myosin II- and phospho-YAP independent pathway during ECM mechanosensing.J. Biol. Chem. 2016; 291: 6096-6110Crossref PubMed Scopus (0) Google Scholar, Dupont et al., 2011Dupont S. Morsut L. Aragona M. Enzo E. Giulitti S. Cordenonsi M. Zanconato F. Le Digabel J. Forcato M. Bicciato S. et al.Role of YAP/TAZ in mechanotransduction.Nature. 2011; 474: 179-183Crossref PubMed Scopus (988) Google Scholar, Rashidian et al., 2015Rashidian J. Le Scolan E. Ji X. Zhu Q. Mulvihill M.M. Nomura D. Luo K. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.Sci. Signal. 2015; 8: ra14Crossref PubMed Scopus (10) Google Scholar, Ren et al., 2010Ren F. Zhang L. Jiang J. Hippo signaling regulates Yorkie nuclear localization and activity through 14-3-3 dependent and independent mechanisms.Dev. Biol. 2010; 337: 303-312Crossref PubMed Scopus (0) Google Scholar, Sorrentino et al., 2014Sorrentino G. Ruggeri N. Specchia V. Cordenonsi M. Mano M. Dupont S. Manfrin A. Ingallina E. Sommaggio R. Piazza S. et al.Metabolic control of YAP and TAZ by the mevalonate pathway.Nat. Cell Biol. 2014; 16: 357-366Crossref PubMed Scopus (134) Google Scholar, Wada et al., 2011Wada K. Itoga K. Okano T. Yonemura S. Sasaki H. Hippo pathway regulation by cell morphology and stress fibers.Development. 2011; 138: 3907-3914Crossref PubMed Scopus (239) Google Scholar, Wang et al., 2014Wang Z. Wu Y. Wang H. Zhang Y. Mei L. Fang X. Zhang X. Zhang F. Chen H. Liu Y. et al.Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.Proc. Natl. Acad. Sci. USA. 2014; 111: E89-E98Crossref PubMed Scopus (81) Google Scholar). Since these pioneering discoveries, the study of YAP/TAZ in mammalian tissues took off to become nowadays a burgeoning field. In several adult organs, YAP/TAZ appear ostensibly dispensable for normal homeostasis but critical to promote tissue repair upon injury (Azzolin et al., 2014Azzolin L. Panciera T. Soligo S. Enzo E. Bicciato S. Dupont S. Bresolin S. Frasson C. Basso G. Guzzardo V. et al.YAP/TAZ incorporation in the beta-catenin destruction complex orchestrates the Wnt response.Cell. 2014; 158: 157-170Abstract Full Text Full Text PDF PubMed Scopus (184) Google Scholar, Bai et al., 2012Bai H. Zhang N. Xu Y. Chen Q. Khan M. Potter J.J. Nayar S.K. Cornish T. Alpini G. Bronk S. et al.Yes-associated protein regulates the hepatic response after bile duct ligation.Hepatology. 2012; 56: 1097-1107Crossref PubMed Scopus (44) Google Scholar, Cai et al., 2010Cai J. Zhang N. Zheng Y. de Wilde R.F. Maitra A. Pan D. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program.Genes Dev. 2010; 24: 2383-2388Crossref PubMed Scopus (185) Google Scholar, Chen et al., 2014Chen Q. Zhang N. Gray R.S. Li H. Ewald A.J. Zahnow C.A. Pan D. A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis.Genes Dev. 2014; 28: 432-437Crossref PubMed Scopus (52) Google Scholar, Lee et al., 2014Lee M.J. Ran Byun M. Furutani-Seiki M. Hong J.H. Jung H.S. YAP and TAZ regulate skin wound healing.J. Invest. Dermatol. 2014; 134: 518-525Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar, Taniguchi et al., 2015Taniguchi K. Wu L.W. Grivennikov S.I. de Jong P.R. Lian I. Yu F.X. Wang K. Ho S.B. Boland B.S. Chang J.T. et al.A gp130-Src-YAP module links inflammation to epithelial regeneration.Nature. 2015; 519: 57-62Crossref PubMed Scopus (78) Google Scholar, Zanconato et al., 2015Zanconato F. Forcato M. Battilana G. Azzolin L. Quaranta E. Bodega B. Rosato A. Bicciato S. Cordenonsi M. Piccolo S. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.Nat. Cell Biol. 2015; 17: 1218-1227Crossref PubMed Scopus (0) Google Scholar, Zhang et al., 2014bZhang W. Nandakumar N. Shi Y. Manzano M. Smith A. Graham G. Gupta S. Vietsch E.E. Laughlin S.Z. Wadhwa M. et al.Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.Sci. Signal. 2014; 7: ra42Crossref PubMed Scopus (88) Google Scholar, Su et al., 2015Su T. Bondar T. Zhou X. Zhang C. He H. Medzhitov R. Two-signal requirement for growth-promoting function of Yap in hepatocytes.Elife. 2015; 4https://doi.org/10.7554/eLife.02948Crossref Scopus (10) Google Scholar). Moreover, YAP/TAZ activation is widespread in many human tumors, where YAP/TAZ have been shown to be essential for cancer initiation, progression, or metastasis (reviewed in Part 2 of this review). The stark contrast between the inconsequentiality of YAP/TAZ inactivation for normal organ function and their absolute requirement for cancer development in the same organs is attractive, highlighting the possibility that targeting YAP/TAZ may display a large therapeutic window. A theme that resonates in this review relates to one of the most appealing aspects of YAP/TAZ biology; that is, they are transducers of the cell's structural features, such as polarity, shape, and cytoskeletal organization. In turn, these features are intimately connected to the cell's location within the 3D architecture of tissues, including the attachment to other cells and to the surrounding extracellular matrix (ECM), and influenced by the chemical and physical features of the cell's microenvironment (Halder et al., 2012Halder G. Dupont S. Piccolo S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ.Nat. Rev. Mol. Cell Biol. 2012; 13: 591-600Crossref PubMed Scopus (244) Google Scholar). Thus, YAP/TAZ respond to cellular events, reflecting changes that occur at the level of whole tissues, setting YAP/TAZ functions and regulations apart from classic growth-factor initiated signaling cascades. This review is divided into three parts. We first outline how YAP/TAZ actually underlie many fundamental traits of cancer cells; in the second part, we review a large body of work on the specific roles of YAP/TAZ in different human tumors and corresponding mouse models. In the third part, we detail the various mechanisms of YAP/TAZ regulation, including Hippo-dependent and non-Hippo-dependent regulations. The reader should be aware of a potentially confounding semantic issue in this field: the phrase “Hippo pathway,” originally indicating a specific set of kinases such as Hippo/MST or LATS ultimately causing YAP/TAZ inhibitory phosphorylation, is in fact now often loosely used to indicate essentially any modality of YAP/TAZ control, and thus essentially as a proxy of “YAP/TAZ activity” itself. In contrast, here we remain adherent to the biochemical definition and thus our “Hippo signaling” invariably refers to the Hippo kinase module (Box 1). We finally close this paper with some future perspectives for YAP/TAZ in cancer biology. YAP/TAZ are transcriptional coactivators that shuttle between the cytoplasm and the nucleus, where they recognize cognate cis-regulatory elements by interacting with other transcription factors, and in particular TEA domain family members (TEAD) (reviewed in Piccolo et al., 2014Piccolo S. Dupont S. Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond.Physiol. Rev. 2014; 94: 1287-1312Crossref PubMed Scopus (188) Google Scholar). Association to TEAD is in fact essential for most, if not all, YAP/TAZ transcriptional effects (Chan et al., 2009Chan S.W. Lim C.J. Loo L.S. Chong Y.F. Huang C. Hong W. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation.J. Biol. Chem. 2009; 284: 14347-14358Crossref PubMed Scopus (0) Google Scholar, Zanconato et al., 2015Zanconato F. Forcato M. Battilana G. Azzolin L. Quaranta E. Bodega B. Rosato A. Bicciato S. Cordenonsi M. Piccolo S. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.Nat. Cell Biol. 2015; 17: 1218-1227Crossref PubMed Scopus (0) Google Scholar, Zhao et al., 2008Zhao B. Ye X. Yu J. Li L. Li W. Li S. Yu J. Lin J.D. Wang C.Y. Chinnaiyan A.M. et al.TEAD mediates YAP-dependent gene induction and growth control.Genes Dev. 2008; 22: 1962-1971Crossref PubMed Scopus (681) Google Scholar). YAP/TAZ/TEAD control the expression of their targets by binding to distant enhancers that contact their regulated promoters through DNA looping; from these enhancers, YAP/TAZ foster enhancer acetylation and transcription elongation (Galli et al., 2015Galli G.G. Carrara M. Yuan W.C. Valdes-Quezada C. Gurung B. Pepe-Mooney B. Zhang T. Geeven G. Gray N.S. de Laat W. et al.YAP drives growth by controlling transcriptional pause release from dynamic enhancers.Mol. Cell. 2015; 60: 328-337Abstract Full Text Full Text PDF PubMed Scopus (28) Google Scholar, Stein et al., 2015Stein C. Bardet A.F. Roma G. Bergling S. Clay I. Ruchti A. Agarinis C. Schmelzle T. Bouwmeester T. Schubeler D. Bauer A. YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers.PLoS Genet. 2015; 11: e1005465Crossref PubMed Google Scholar, Zanconato et al., 2015Zanconato F. Forcato M. Battilana G. Azzolin L. Quaranta E. Bodega B. Rosato A. Bicciato S. Cordenonsi M. Piccolo S. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.Nat. Cell Biol. 2015; 17: 1218-1227Crossref PubMed Scopus (0) Google Scholar). YAP/TAZ empower several of the key attributes of cancer cells (Figure 1) (Hanahan and Weinberg, 2011Hanahan D. Weinberg R.A. Hallmarks of cancer: the next generation.Cell. 2011; 144: 646-674Abstract Full Text Full Text PDF PubMed Scopus (16211) Google Scholar). To start, sustained activation of YAP/TAZ promotes aberrant cell proliferation (Camargo et al., 2007Camargo F.D. Gokhale S. Johnnidis J.B. Fu D. Bell G.W. Jaenisch R. Brummelkamp T.R. YAP1 increases organ size and expands undifferentiated progenitor cells.Curr. Biol. 2007; 17: 2054-2060Abstract Full Text Full Text PDF PubMed Scopus (495) Google Scholar, Chan et al., 2008Chan S.W. Lim C.J. Guo K. Ng C.P. Lee I. Hunziker W. Zeng Q. Hong W. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells.Cancer Res. 2008; 68: 2592-2598Crossref PubMed Scopus (222) Google Scholar, Dong et al., 2007Dong J. Feldmann G. Huang J. Wu S. Zhang N. Comerford S.A. Gayyed M.F. Anders R.A. Maitra A. Pan D. Elucidation